Showing results (711-720 of 809) with videos related to

Sort By:
Pageof 81
Antiviral Research|November 20, 2023
Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunizationQiu-Yan Zhang, Hong-Qing Zhang, Ya-Nan Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer|October 9, 2016
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control studyLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2022
Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinomaSai-Lan Liu, Xue-Song Sun, Qiu-Yan Chen, et al.
BMJ Oncology|August 5, 2025
Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinomaJie Chen, Hui Cheng, Yi-Fu Li, et al.
Cell Reports|April 13, 2025
Alveolar macrophages critically control infection by seasonal human coronavirus OC43 to avoid severe pneumoniaXuan Zhong, Tian Xie, Su-Yun Wang, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinomaSai-Lan Liu, Li-Juan Bian, Ze-Xian Liu, et al.
Pageof 81